ALT Stock Analysis: Buy, Sell, or Hold?
ALT - Altimmune, Inc. Common Stock
$5.55
0.45 (8.82%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
26d
Get Alerted When ALT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
80 traders called ALT this week
79% bullish • 36 bearish
79% bullish • 36 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ALT is 8.8% above fair value ($5.10). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ALT is 8.8% above fair value ($5.10). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ALT is currently trading at $5.55, which is considered extended relative to its 30-day fair value range of $3.69 to $5.10.
Technical Outlook: Technically, ALT is in a strong downtrend. Immediate support is located at $4.03, while resistance sits at $6.44. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: ALT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.67 (+246.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALT is in a strong downtrend. Immediate support is located at $4.03, while resistance sits at $6.44. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: ALT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.67 (+246.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$3.69 -
$5.10
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
Protect Your Profits
Holding ALT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.8% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.8%)
- BULLISH: Trading 246.4% below Wall St target ($17.67)
- CAUTION: Extended 8.8% above fair value - wait for pullback
Fair Price Analysis
30-Day Fair Range
$3.69 -
$5.10
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$4.03
Resistance Level
$6.44
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.10
Wall Street Target
$17.67
(+246.4%)
Last updated: January 30, 2026 2:11 PM ET
Data refreshes hourly during market hours. Next update: 3:11 PM
Data refreshes hourly during market hours. Next update: 3:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced ALT Option Strategies
Professional options setups generated by AI based on today's ALT price and gamma walls.
